Ballymore Resources is up on the identification of lengthy gold corridor at Dittmer.
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Ballymore Resources (ASX:BMR) ended Wednesday’s trading day up almost +12% after the company reported a significant expansion of the scale and prospectivity of the Dittmer gold project in North Queensland.

Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

Recent field work, including stream sediment sampling, soil sampling and prospecting, has extended the Dittmer corridor to more than five kilometres, with gold values increasing towards the peak of Mount Quandong.

Ballymore’s MD, David A-Izzeddin, said the results reinforce the view that Dittmer forms part of a large, under-explored gold-copper-silver mineralised system.

“These results provide compelling evidence that a large-scale gold plus copper system is emerging at Dittmer. We have now traced gold mineralisation over more than five km, with high-grade results and visible gold pointing to a significant source, particularly in the Mount Quandong area,” Mr A-Izzeddin said.

“Importantly, the most significant anomalies are associated with catchments draining the upper slopes of Mount Quandong, where we have also mapped strongly altered and leached breccias associated with a large magnetic low. Soil sampling also shows a clear increase in gold values toward the summit, suggesting a localised and potentially significant mineralised source.”

Mr A-Izzeddin told Ballymore shareholders that underground development at Dittmer is progressing well despite over 800mm of rain falling this year.

“With drilling planned for Q2 2026, we are well-positioned to commence testing of these targets and unlocking the broader potential of the Dittmer corridor. Further field work across the Mount Quandong area is also planned following the wet season.”

Recent field work was designed to assess the southern extent of the Dittmer corridor, a pronounced mineralised trend. Previous work in CY25 identified visible gold in 11 stream sediment samples, primarily in the Lady Denise and Jim’s prospect areas around three to four km south of the Dittmer Project.

An additional 34 stream sediment samples have now been collected one to two km further south along the eastern flank of Mount Quandong. Significant alluvial mining has occurred historically in this area.

Extremely high-grade gold values have been returned with the best results reported from samples collected from creeks draining the upper slopes of Mount Quandong, suggesting a nearby bedrock source. Visible gold was identified in four samples draining the peak of Mount Quandong.

Significant gold assay results reported by Ballymore in this area include ten samples of 100 parts per billion (ppb) gold, five samples at 1,000 ppb gold, as well as a peak result of 24,288 ppb gold from Gold Creek.

BMR is up +11.8% to 19cps. Mkt cap $35.30M.

Join the discussion: See what HotCopper users are saying about Ballymore Resources Ltd and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

bmr by the numbers
More From The Market Online

Heading into CYQ2, Magnum keeps eyes on drilling as auger campaign fires up

Magnum M&E has its eyes on a whopping 10,000-metre auger drill run on-site at its newly…

Infotrust expands federal services with Catalyst Cyber acquisition

Infotrust is paying $5 million to expand its federal government offering with the Catalyst Cyber acquisition

High-Tech is ‘operationaly ready’ and waiting on fuel to fire up Mt Fisher drilling

High-Tech Metals is confident the mineral resource at the new Mt Fisher gold project can be…

The biotech inflection point, and why it’s a ‘grand final’ for Paradigm Biopharma in CY26

The crucial junction in Phase Three trials is exactly where we find Paradigm Biopharmaceuticals as the…